38 year old male admitted to an inpatient psychiatric hospital with increased paranoia and auditory hallucinations. Voices are telling him to hurt himself and saying other derogatory comments about himself. His past medical history includes schizophrenia, hypertension, obesity, and seasonal allergies. He has been compliant with his medications lately but does admit he sometimes forgets to take his morning medications.

His current medications include:

Risperidone 2 mg BID  *Has been on this medication for 6 months

Olanzapine 5 mg every 6 hours as needed (he states he has used this frequently in the last couple days otherwise usually takes this every night at bedtime)  *This was added 1 month ago

Cetirizine 10 mg daily as needed

Lisinopril 20 mg daily

Past trials for schizophrenia include haloperidol (experienced akathisia) and quetiapine  (wanted to stop this after gaining 10 lbs in 1 month)

Blood pressure on admit is 135/88, HR 92, RR 18. BMI 32.4

What is your next approach for treatment in this patient and why? What monitoring/labs do you need? Please list mechanism of action of each current medication and any new medications you recommend.

ANSWER

Treatment Approach for a 38-Year-Old Male with Schizophrenia Experiencing Paranoia and Auditory Hallucinations

Introduction

The case presents a 38-year-old male with a history of schizophrenia who has been admitted to an inpatient psychiatric hospital due to increased paranoia and auditory hallucinations, including voices encouraging self-harm. The patient has a complex medical history, including hypertension, obesity, and seasonal allergies. He is currently taking Risperidone and Olanzapine for his schizophrenia, as well as Lisinopril for hypertension and Cetirizine for allergies. This essay outlines the next steps in his treatment, considering medication adjustments, monitoring, and necessary laboratory tests.

Assessment and Initial Considerations

The patient’s presentation of increased paranoia, auditory hallucinations, and self-harm ideation indicates an exacerbation of his underlying schizophrenia. Given his complex medical history and medication regimen, a thorough assessment is essential. It is crucial to evaluate his medication adherence, identify recent stressors or triggers, and assess for any potential substance use contributing to his symptoms. Additionally, monitoring vital signs, including blood pressure, heart rate, respiratory rate, and BMI, is essential to address his comorbid conditions effectively.

Review of Current Medications

1. Risperidone (2 mg BID):
Mechanism of Action: Risperidone is an atypical antipsychotic that primarily acts as a dopamine D2 receptor antagonist, thereby reducing psychotic symptoms.

2. Olanzapine (5 mg every 6 hours as needed):
Mechanism of Action: Olanzapine, like Risperidone, is an atypical antipsychotic, but it also antagonizes serotonin receptors. It is prescribed for acute symptom management.

3. Cetirizine (10 mg daily as needed):
Mechanism of Action: Cetirizine is a second-generation antihistamine that blocks histamine receptors, providing relief from allergy symptoms.

4. Lisinopril (20 mg daily):
Mechanism of Action: Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor used to manage hypertension by reducing blood pressure.

Treatment Plan and Rationale

Given the patient’s current presentation, the treatment approach should focus on stabilizing his psychiatric symptoms and addressing his medical comorbidities. Here are the next steps:

1. Medication Review and Adjustment:
Risperidone has been the patient’s mainstay antipsychotic for six months, suggesting a potential need for a dose adjustment or a switch to an alternative atypical antipsychotic.
Olanzapine, which was added one month ago, could be contributing to sedation and weight gain. Reducing its frequency or considering an alternative antipsychotic may be necessary.
The patient’s history of haloperidol-induced akathisia and quetiapine-induced weight gain should inform the choice of the next antipsychotic. Aripiprazole, a partial dopamine agonist, might be considered, given its favorable side effect profile.

2. Monitoring and Labs:
Vital signs, including blood pressure and BMI, should be monitored regularly to assess the patient’s response to treatment and manage comorbid conditions.
Fasting blood glucose and lipid panels should be obtained to monitor metabolic side effects of antipsychotic medications.
Serum drug levels for the current antipsychotic (Risperidone) may be considered to assess medication adherence.

3. Supportive Psychotherapy:
The patient should be engaged in supportive psychotherapy to address stressors, coping mechanisms, and adherence to his treatment plan.

Conclusion

The treatment approach for the 38-year-old male with schizophrenia experiencing paranoia and auditory hallucinations should prioritize stabilizing his psychiatric symptoms, adjusting antipsychotic medications to minimize side effects, and monitoring comorbid medical conditions. A comprehensive assessment and collaboration among psychiatric and medical teams are essential to provide safe, effective care tailored to the patient’s unique needs. Regular monitoring and psychotherapy will contribute to the patient’s overall well-being and long-term management of his condit